1 It has been reported previously that clonidine can potentiate tyramine-evoked mydriasis on the pain-free side of cluster headache patients. We examined whether a single oral dose of clonidine (200 mg) can also potentiate tyramineevoked mydriasis in healthy subjects, using mydriasis to methoxamine, a directly acting sympathomimetic amine, as a control. 2 Eight healthy male volunteers participated in four weekly sessions. In the first two sessions (Experiment 1) the effect of clonidine or placebo on the mydriasis to tyramine hydrochloride eyedrops (75 m; 2×10 ml), and in the last two sessions ( Experiment 2) the effect of clonidine or placebo on the mydriasis to methoxamine hydrochloride eyedrops (20 m; 2×10 ml) was examined. In both experiments subjects were allocated to drugs and sessions according to a double-blind balanced design. In both experiments, pupil diameter of both the treated and the untreated eyes was recorded in standard ambient light and in the dark, before, and 2 h after clonidine/placebo, via binocular infrared television pupillometry. Salivation (dental roll technique), systolic and diastolic blood pressure (sitting), heart rate, and self-ratings of mood and feelings (visual analogue scales), were also measured before, and 2 h after the ingestion of clonidine or placebo. 3 Both tyramine and methoxamine produced a significant mydriasis, which was more prominent in the light condition (change in resting pupil size; mm±s.e.mean: tyramine/light 1.05±0.28; tyramine/dark: 0.73±0.15; methoxamine/light: 1.65±0.28; methoxamine/dark: 0.85±0.15). Clonidine produced a significant miosis in the untreated eye which was more prominent in the light condition (change in resting pupil size; mm±s.e. significant miosis in human subjects, and fails to potentiate tyramine-evoked mydriasis. This indicates that the pupil on the asymptomatic side of cluster headache patients is affected differently from the pupils of healthy volunteers by tyramine and/or clonidine.
Introduction
Since apart from the study of Fanciullacci et al.
[14] on cluster headache patients there is no information on a possible interaction between clonidine and indirectly Tyramine is an indirectly acting sympathomimetic amine: it exerts its pharmacological actions via noradreacting sympathomimetic amines, in the present experiment we examined the effects of clonidine on tyraminenaline released from storage sites in sympathetic nerve endings [1 ] . Tyramine eyedrops have been used successevoked mydriasis in healthy subjects. We used methoxamine-evoked mydriasis as a control: methoxamine is a fully in ophthalmic pharmacology as a diagnostic tool in Horner's syndrome [2 ] and in cluster headache directly acting a 1 -adrenoceptor agonist whose effect is not dependent on the size of the presynaptic noradrenaline patients [ 3, 4] . In both clinical syndromes, indirectly acting sympathomimetic amines such as tyramine and store [17 ] . Some of these results have been communicated to the British Pharmacological Society [18] . hydroxyamphetamine may have a reduced effectiveness in evoking mydriasis. The reduced effectiveness of the indirectly acting sympathomimetic amines is attributed to an impairment of the uptake and/or noradrenaline storage mechanisms in the terminals of the peripheral Methods sympathetic neurones innervating the dilator muscle of the iris [2, 3, 5] . Furthermore, in Horner's syndrome the Ethical considerations reduced effectiveness of tyramine is regarded as evidence for a postganglionic lesion.
The study protocol was approved by the University of Nottingham Medical School Ethics Committee. All Clonidine is an a 2 -adrenoceptor agonist with both central and peripheral actions. The central action of volunteers gave their written informed consent following a verbal explanation of the study and after reading a clonidine leads to a decrease in sympathetic outflow; this is attributed to the stimulation of inhibitory a 2 -detailed information sheet. adrenoceptors on central noradrenergic neurones [6 ] . Clonidine affects resting pupil size differently in different species: in rats and cats it causes mydriasis [ 7, 8] . In Subjects rabbits [11] and in humans [ 12, 13, 14] clonidine causes miosis which is reversed by the a 2 -adrenoceptor antagonEight healthy male volunteers aged 18-22 years (mean±s.d., 19.0±1.2), body weight 68-81 kg ist idazoxan [12, 13] . Whereas the mydriatic effect of clonidine in rats and cats has been attributed to the (mean±s.d., 75.1±4.5) participated in the study. Each subject completed a brief medical history and underwent stimulation of inhibitory postsynaptic a 2 -adrenoceptors in the third nerve nucleus in the midbrain [9, 10] , the a complete physical examination. Subjects had not participated in drug studies within 3 months of the start miotic effect of clonidine in humans is more likely to be due to stimulation of presynaptic inhibitory a 2 -adrenoof the present study and had not used any drug within the 14 days preceding the study. They were requested ceptors on central noradrenergic neurones resulting in a reduction in sympathetic outflow.
to stop smoking and to avoid drinking alcohol, coffee and other caffeine-containing beverages for at least 12 h More recently, Fanciullacci et al. [14 ] examined the effects of systemically administered clonidine on tyrambefore each experimental session. All subjects indicated compliance with these requests. ine-evoked mydriasis in cluster headache patients. These authors found that, in agreement with previous reports, tyramine was less effective as a mydriatic on the painside pupil. Furthermore, clonidine potentiated tyramineDrugs evoked mydriasis on the pain-free side, without affecting the response on the pain side. The authors postulated Clonidine hydrochloride 200 mg and placebo were administered orally, and tyramine HCl (75 m, 2×10 ml ) that the potentiation of the tyramine-evoked mydriasis on the pain-free side was due to a reduction in and methoxamine HCl (20 m, 2×10 ml ) were instilled in the left conjuctival sac. sympathetic outflow caused by clonidine, resulting in the accumulation of noradrenaline in the noradrenergic nerve terminals innervating the iris, leading to the release of more noradrenaline in response to tyramine.
Apparatus and tests In this context, it is of interest that it has been suggested by other authors [15, 16] that the variability of the Pupillometry An infrared binocular television pupillometer (TVP 1015B Applied Sciences Laboratory, mydriatic response to indirectly acting sympathomimetic amines, such as hydroxy-amphetamine and tyramine, Waltham, MA, USA) was used for the recording of the resting pupil size in darkness after previous dark might reflect changes in the level of sympathetic activity and thus in the degree of repleteness of the prejunctional adaptation, and in ambient light (32 Cd m−2). Pupil diameter measures were recorded both in dark and light noradrenaline stores. in order to control for possible errors associated with sessions, one of which was associated with tyramine/ clonidine and the other one with tyramine/placebo. the measurement of the effects of mydriatic drugs, such as a 'ceiling effect' in the dark [19] and interaction Subjects were allocated to drugs and sessions according to a double-blind balanced design. At the beginning of between the two eyes in the light [20 ] (for details, see Discussion). The recordings took place in a sound each session, after a 10 min rest period, the subjects underwent the pre-treatment tests (salivation, cardiovasattenuated room and the subjects fixed their gaze on a dim red spot of light positioned approximately 2.5 m in cular measures, pupillometry, mood ratings) after which they ingested the capsule. Identical post-treatment tests front of them. Pupillary measures were digitized and stored on a floppy-disk for off-line analysis. Resting were carried out 120 min after ingestion. Tyramine hydrochloride eyedrops (75 m; 2×10 ml) were instilled pupil diameter was calculated as the mean of three consecutive recordings of 15 s separated by 5 s intervals.
into their left conjuctival sacs 40 min prior to the posttreatment tests. In Experiment 2 the same procedures were followed Salivation Salivation was measured using the dental roll technique [21 ] . Three cotton-wool dental rolls (size except that 50 min prior to the post-treatment tests methoxamine hydrochloride eyedrops (20 m; 2×10 ml ) 2 ) were placed in the mouth for 1 min, two buccally and one sublingually, and the increase in weight was were instilled into their left conjuctival sacs. The timing of the post-drug tests was based on the measured. The mean of three measurements, taken at 5 min intervals was used for analysis. Salivary output single-dose pharmacokinetics of clonidine. It has been reported that peak autonomic and behavioural changes was measured before and after treatment and the change in mean salivary output was taken as the response.
are obtained 2 h after oral administration of a single 200 mg dose [25] . The timing of the instillation of tyramine and methoxamine eyedrops was based on Cardiovascular measures Systolic and diastolic blood pressure and heart rate (sitting) were measured with an previous pilot studies in our laboratory showing that 40 and 50 min, respectively, are required to attain peak electroaneroid sphygmomanometer (Bosch, GojoPrestige). Measurements were taken before and after responses. treatment with the systemically administered drug; the pre-post treatment change was taken as the effect of the drug.
Data analysis
Student's t-test (paired comparisons) was used to V isual analogue mood rating scale A 16-item scale [ 22, 23] was administered before and after treatment.
compare the effects of treatment on the resting pupil size in darkness and ambient light (clonidine or placebo For the evaluation of the pre-treatment levels of mood and feelings the pre-treatment raw scores on each item for the untreated eye, clonidine-tyramine and clonidinemethoxamine for the treated eye), salivation, cardiovaswere multiplied with the factor loadings derived from a factor analysis, and the 16 items were divided into three cular measures and visual analogue scales. groups: factor 1 ('alertness'; 9 items); factor 2 ('contentment'; 5 items); factor 3 ('anxiety'; 2 items) [24 ] . The mean value (mm) was calculated for each factor, for each subject on each occasion, and the mean value was Results calculated for the whole group of experimental subjects. For the assessment of the effects of treatment on mood
Resting pupil diameter and feelings, the post-pre treatment differences were taken for each item, and each subject in every session, The pre-treatment pupil sizes (right eye; absolute diameters in mm) are shown in Table 1 . The effect of and these were multiplied by the factor loadings. Thereafter, the calculation was as described for the preclonidine on resting pupil diameter (right untreated eye) is shown in Figure 1 In both experiments the effect of clonidine was greater in the light than in the dark weekly interval.
In Experiment 1 subjects participated in two weekly (Experiment 1: P<0.01; Experiment 2: P<0.02). 
05). T yramine-evoked mydriasis
The effect of clonidine on tyramine-evoked mydriasis is Cardiovascular measures shown in Figure 2 . Tyramine caused a significant mydriasis both in light and in the dark. Change in The effects of clonidine on heart rate, systolic and resting pupil size (mm; mean±s.e.mean): light: 1.05±0. 28 diastolic blood pressure are shown in Table 2 . Clonidine (P<0.008); dark: 0.73±0.15 (P<0.002). Tyraminereduced systolic blood pressure in both experiments evoked mydriasis was greater in the light than in the (Experiment 1: P<0.02, Experiment 2: P<0.002), and dark but this difference was not significant diastolic blood pressure in Experiment 2: P<0.02). (0.1>P >0.05).
Clonidine had no significant effect on heart rate.
Methoxamine-evoked mydriasis
Rating of mood and feelings The effect of clonidine on methoxamine-evoked mydriasis is shown in Figure 2 . Methoxamine caused a
The effects of clonidine on the 'alertness', 'anxiety' and significant mydriasis both in the light and in the dark.
'contentment' factors derived from the 16 visual analogue Change in resting pupil size (mm; mean±s.e.mean) was: scales used, are shown in Table 2 . Clonidine reduced light: 1.65±0.28 (P<0.001); dark: 0.85±0.15 (P<0.002).
'anxiety' in Experiment 1 (P<0.05), and 'alertness' in However, this response was not significantly affected by Experiment 2 (P<0.01). The contentment factor was clonidine. The methoxamine-evoked mydriasis was not affected significantly. greater in light than in the dark (P<0.02).
Discussion Salivation
The effect of clonidine on salivary output is shown in
The effects of two locally instilled mydriatic drugs (tyramine hydrochloride and methoxamine hydro- Table 2 . Clonidine reduced salivation in both chloride) and of systemically administered clonidine on mediated pupil dilatation, the miotic effect of clonidine may reflect the central sympatholytic effect of the drug. pupil diameter were studied, both in the dark and in the light under standard illumination conditions. The Interestingly, the miotic effect of clonidine was lightdependent: the clonidine induced miosis was more reason for comparing the effects of the drugs under two illumination conditions was that it is difficult to study pronounced in the light than in the dark. This observation may explain why some previous studies mydriatic drugs in the dark, where the initial pupil diameter is large and the size of the mydriasis may be carried out in the dark [30 ] failed to detect the miotic effect of clonidine. The light-dependency of the miotic limited by a ceiling effect [ 19] . In the light, however, a possible source of error could be an interaction between effect of clonidine suggests that the relationship between the opposing sympathetic and parasympathetic innerthe two eyes: mydriasis in one eye can be accompanied by a consensual miosis in the fellow eye [20 ] . In the vations of the iris changes depending on the lighting conditions: not only the parasympathetic but also the present experiment, as expected, the pupil diameter was consistently smaller under the light than under the dark sympathetic impulse flow may be greater in the light than in the dark. Therefore, the removal of the condition. The effects of both the locally instilled mydriatics and of systemically administered clonidine sympathetic influence by clonidine may result in an enhanced miotic effect in the light. It should be noted, were qualitatively similar under the two illumination conditions.
however, that the synergistic interaction between light and clonidine may be observable only under tonic In agreement with previous reports, both tyramine hydrochloride [26, 27] , and methoxamine hydrochloride conditions since clonidine failed to modify the amplitudes of a series of pupillary light reflex responses [ 28, 26] evoked consistent mydriatic responses. Furthermore, the mydriasis to either drug was greater evoked by brief (200 ms) light pulses [30] . Furthermore, electrophysiological studies indicate that a phasic light in the light than in the dark, presumably due to the curtailment of the mydriasis in the dark by the operation stimulus has an inhibitory effect on on-going sympathetic activity recorded in the dark [ 31] . of a ceiling effect [ 19] . It is important to note that the doses of both mydriatic drugs used in these experiments Apart from affecting resting pupil diameter, clonidine had other significant autonomic effects, such as were clearly submaximal in the light, both drugs dilating the pupil to a diameter of approximately 6.3 mm.
reductions in salivary flow, and systolic and diastolic blood pressures. These effects of clonidine are wellHowever, in the dark both drugs dilated the pupil to a size of just over 9 mm, which corresponds to the documented in the literature [ 6] . The cardiovascular effects of clonidine are usually attributed to the central 'ceiling' [29 ] .
Clonidine had a miotic effect in both experiments. sympatholytic effect of the drug [6 ] . The reduction in salivation is more difficult to interpret: the activation of This observation is consistent with some previous reports [12] [13] [14] , although other authors [30 ] could release-modulating a 2 -adrenoceptors on cholinergic nerve endings in the salivary glands has been proposed not detect a miotic effect of clonidine. Since pupil size reflects the balance between parasympathetically as a possible mechanism in the dog [32] . However, a central mechanism may also be involved since the mediated pupil constriction and sympathetically
